Epitome Pharmaceuticals Ltd.

Epitome Pharmaceuticals Ltd. (Epitome) is a privately held biotech company that is engaged in research, development and commercialization of over-the- counter therapeutics such as pain relief products and analgesics. The company currently develops products to stabilize the dose-response of anticoagulant and double the biopsy tissues. It also develops cold sore prevention, topical treatment products for headache pain, topical analgesic. Epitome also licensed two product including, Polyphenon E for the treatment of HPV infections from Mitsui Norin Company, Japan and a Topical Therapy for the treatment of chronic pain from Dalhousie University, Canada. The company trademark VEREGEN has approved by FDA. Epitome is headquartered at Halifax in Nova Scotia, Canada.

Street: 
5162 Duke St.
City: 
Halifax
Postcode: 
B3J 1N7
Federal State : 
Canada
WebSite: 
www.epitomepharm.com
Fax: 
1-212-3546412

Company Index Score

Current Index Score Historical Index Score
  • Epitome Pharmaceuticals Ltd. currently scores 50 % in the index.
  • Epitome Pharmaceuticals Ltd. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Epitome Pharmaceuticals Ltd. is currently ranked 1 out of 4535 companies. This is in the top 0.022 % percent of Pharmaceutical companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets